RHON-KLINIKUM AGRHON-KLINIKUM AGRHON-KLINIKUM AG

RHON-KLINIKUM AG

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
Revenue estimate
Market capitalization
‪863.51 M‬EUR
‪38.71 M‬EUR
‪1.67 B‬EUR
‪4.41 M‬
Beta (1Y)
0.46

About RHOEN-KLINIKUM AG

CEO
Tobias Kaltenbach
Headquarters
Bad Neustadt an der Saale
Employees (FY)
‪18.25 K‬
Founded
1973
ISIN
DE0007042301
FIGI
BBG000BG2XR7
Rhön-Klinikum AG engages in the provision of healthcare services. It operates hospitals and medical care centers that offers basic and standard, intermediate, maximum, and specialist care. It offers outpatient-inpatient basic and standard care in portal clinics and medical care centers. The company was founded by Eugen Münch in 1973 and is headquartered in Bad Neustadt an der Saale, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RHK is 13.000 EUR — it has increased by 2.36% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange RHON-KLINIKUM AG stocks are traded under the ticker RHK.
RHON-KLINIKUM AG is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
RHK stock is 3.91% volatile and has beta coefficient of 0.46. Check out the list of the most volatile stocks — is RHON-KLINIKUM AG there?
RHON-KLINIKUM AG revenue for the last quarter amounts to ‪320.00 M‬ EUR despite the estimated figure of ‪318.40 M‬ EUR. In the next quarter revenue is expected to reach ‪319.25 M‬ EUR.
Yes, you can track RHON-KLINIKUM AG financials in yearly and quarterly reports right on TradingView.
RHK stock has risen by 20.37% compared to the previous week, the month change is a 20.37% rise, over the last year RHON-KLINIKUM AG has showed a 0.76% decrease.
RHK net income for the last quarter is ‪15.55 M‬ EUR, while the quarter before that showed ‪11.17 M‬ EUR of net income which accounts for 39.21% change. Track more RHON-KLINIKUM AG financial stats to get the full picture.
Today RHON-KLINIKUM AG has the market capitalization of ‪856.81 M‬, it has increased by 6.31% over the last week.
Yes, RHK dividends are paid annually. The last dividend per share was 0.15 EUR. As of today, Dividend Yield (TTM)% is 1.17%. Tracking RHON-KLINIKUM AG dividends might help you take more informed decisions.
Like other stocks, RHK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RHON-KLINIKUM AG stock right from TradingView charts — choose your broker and connect to your account.
RHK reached its all-time high on Feb 1, 2018 with the price of 31.800 EUR, and its all-time low was 5.932 EUR and was reached on Mar 5, 2003.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has ‪18.25 K‬ employees. See our rating of the largest employees — is RHON-KLINIKUM AG on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RHON-KLINIKUM AG technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RHON-KLINIKUM AG stock shows the neutral signal. See more of RHON-KLINIKUM AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RHON-KLINIKUM AG EBITDA is ‪50.05 M‬ EUR, and current EBITDA margin is 2.73%. See more stats in RHON-KLINIKUM AG financial statements.